MYC and hepatocellular carcinoma: It is worth noting that miR-26a could suppress MYC by targeting the Wnt pathway coactivator, cyclin-dependent kinase 8 (CDK8), to inhibit progression and metastasis of hepatocellular carcinoma [21].